Anti-cancer drug safe and effective for treating light chain (AL) amyloidosis
There's a new treatment option available for patients with AL amyloidosis: daratumumab.
Jan 27, 2020
0
10
There's a new treatment option available for patients with AL amyloidosis: daratumumab.
Jan 27, 2020
0
10
Although classical Hodgkin's lymphoma is generally easily treatable today, many aspects of the disease still remain a mystery. A team at the Max DelbrĂĽck Center led by Professor Claus Scheidereit has now identified an important ...
May 14, 2019
0
6
Mount Sinai and Memorial Sloan Kettering Cancer Center (MSK) researchers have identified therapies that can help patients with the blood cancer multiple myeloma who try an immunotherapy known as CAR-T only to find their cancer ...
Nov 4, 2022
0
10
A novel clot-busting drug formulated and tested by University of Manchester scientists is able to effectively restore blood flow in the brains of mice, opening the door for a safer and more effective stroke treatment.
Nov 15, 2021
0
58
(Medical Xpress) -- Having a virtual copy of a patients blood in a computer would be a boon to researchers and doctors. They could examine a simulated heart attack caused by blood clotting in a diseased coronary artery ...
May 1, 2012
0
0
In two recent studies, a team of scientists reports the mechanisms underlying two distinct immunological disorders affecting children and adults. Stephanie Humblet-Baron (VIB-KU Leuven) was the researcher at the helm of both ...
Dec 21, 2018
0
2
"Why did my child get cancer?"
Sep 8, 2022
0
35
An antibody-based treatment can gently and effectively eliminate diseased blood-forming stem cells in the bone marrow to prepare for the transplantation of healthy stem cells, according to a study in mice by researchers at ...
Feb 11, 2019
0
133
Scientists have found a way to lower stroke risk in sickle cell patients that opens a gateway of potential treatments for inflammation and clotting stemming from conditions such as COVID-19. For the first time, they investigated ...
Jan 28, 2021
0
1
Patients with some types of lymphoma that become resistant to standard treatments may benefit from a therapy that University of Wisconsin–Madison researchers are evaluating after they discovered a key process that fuels ...
Mar 16, 2024
0
48